News
Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...
Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...
M&A and IPOs got off to a quick start in 2025 only to crash into a wall of policy challenges. Upfront payment for licensing ...
Marc Watkins is assistant director of academic innovation at the University of Mississippi, where he directs the AI institute for teachers. He writes regularly about generative AI in education on his ...
2d
MedPage Today on MSNInitial Treatment for Patients With Newly Diagnosed Multiple Myeloma"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...
Newly elected member for Griffith, Renee Coffey, grew up with no illusions about the pressures of the job: Kevin Rudd was a ...
By MANSUR UMAR Recently, Governor Uba Sani made out time from his very busy schedule to speak very passionately and frankly about the essence of his unique resort to very little or no partisan ...
3d
The Punch on MSNSanwo-Olu, crush the cultism menaceVIOLENT cultism has become rife in Lagos. The social malaise comes from the breakdown of the family value system, the poor enforcement of law, complicity of the political class, and a buoyant economy ...
But there’s much to love too. Physical comedy and contemporary additions to the script are mined for humour. The deep kinship ...
Oncopeptides AB advanced stock charts by Barron's. View 0RN4 historical stock data and compare to other stocks, and exchanges.
5d
WSAV-TV on MSNSeveral new drugs added to list of GA schedule I substancesA new bill signed into law by Georgia Governor Brian Kemp adds four news drugs to the list of Schedule I controlled ...
Sequel Pharma Executes Agreement with CDMO for Drug Product ManufacturingMISSISSAUGA, Ontario, May 05, 2025 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results